期刊文献+

比较目测法和T/Lratio-ROC法在^68Ga-DOTATATE PET/CT显像中对神经内分泌肿瘤的诊断效能 被引量:5

Comparison of visual interpretation versus T/Lratio-ROC method in diagnosis of neuroendocrine tumors based on ^68Ga-DOTATATE PET/CT imaging
在线阅读 下载PDF
导出
摘要 目的比较目测法和T/Lratio-ROC分析法在^68Ga-DOTATATE PET/CT显像对神经内分泌肿瘤(neuroendocrine tumors,NETs)的诊断效能。方法回顾性分析2018年7月-2019年1月于我中心行^68Ga-DOTATATE PET/CT检查疑似神经内分泌肿瘤并经病理确诊的32例患者,其中男性18例,女性14例;年龄15~84岁。在肝及病变部位勾画感兴趣区,测定肝部位平均SUV值(SUVmean)及病变部位的最大SUV值(SUVmax),肿瘤/肝比值(T/Lratio)定义为TumorSUVmax/LiverSUVmean。分别使用目测法和T/Lratio-ROC分析法进行诊断。目测法以肉眼观察^68Ga-DOTATATE PET/CT成像中病变部位的放射性浓聚程度超过肝实质作为NETs阳性的标准。T/Lratio-ROC分析法是对T/Lratio进行ROC分析,以大于cut-off值为阳性标准。以上两种方法均以病理结果为金标准进行诊断性评价。结果1)病理结果:NETs 26例,其中嗜铬细胞瘤10例,嗜铬细胞瘤合并副神经节瘤2例,副神经节瘤3例,胰腺NETs 5例,直肠NETs 2例,嗜铬细胞瘤合并甲状腺髓样癌1例,肝门区神经内分泌癌1例,肝及十二指肠NETs各1例。非NETs 6例,其中肾上腺皮质腺癌、肾神经源性肿瘤、肾血管平滑肌脂肪瘤、肾上腺节细胞神经瘤、孤立性纤维瘤及骨纤维不良各1例。2)目测法:^68Ga-DOTATATE阳性23例,22例为NETs。^68Ga-DOTATATE阴性9例,4例为假阴性。目测法诊断NETs的灵敏度、特异度和准确度分别为84.62%、83.33%、84.38%,阳性预测值和阴性预测值分别为95.65%、55.56%。3)T/Lratio-ROC分析法(T/Lratio cut-off值=1.48):^68Ga-DOTATATE阳性21例均为NETs。^68Ga-DOTATATE阴性11例,5例为假阴性。T/Lratio-ROC分析法诊断NETs的灵敏度、特异度和准确度分别为80.80%、100%、84.38%,阳性预测值和阴性预测值分别为100%、54.55%。结论目测法和T/Lratio-ROC分析法在^68Ga-DOTATATE PET/CT显像中对NETs均具有较好的诊断效能,可用于NETs的定位及定性诊断。 Objective To compare the diagnostic efficacy of visual interpretation versus T/Lratio-ROC method based on ^68Ga-DOTATATE PET/CT imaging for neuroendocrine tumors (NETs).Methods A total of 32 patients (18 males and 14 females with age of 15-84 yeas) underwent ^68Ga-DOTATATE PET/CT in our center from July 2018 to January 2019 and confirmed by pathology were included in the retrospective analysis.Their clinical data and pathological results were collected.The area of interest (ROI) was delineated in the liver and the lesion site.The mean SUV value (SUVmean) of the liver and the maximum SUV value (SUVmax) of the lesion were measured.The ratio of tumor to liver (T/Lratio) was defined as TSUVmax/LSUVmean.Visual interpretation and T/Lratio-ROC methods were used to analyze the diagnostic accuracy.By visual interpretation,uptake in the lesion higher than that in the liver was regarded as positive to diagnosis of NETs.ROC analysis was used to analyze the performance of T/Lratio to diagnose NETs.The pathological result was the golden standard.Results Pathological results showed that 26 cases had NETs,including 10 cases of pheochromocytoma,2 cases of pheochromocytoma combined with paraganglioma,3 cases of paraganglioma,5 cases of pancreatic neuroendocrine tumors,2 cases of rectal neuroendocrine tumors,1 case of pheochromocytoma combined with medullary thyroid carcinoma,1 case of hilar neuroendocrine carcinoma,1 case of hepatic and 1 case of duodeneal NET.Six cases had non-NETs,including 1 case of adrenal cortical adenocarcinoma,1 case of renal neurogenic tumor,1 case of renal angiomyolipoma,1 case of adrenal ganglion cell neuroma,1 case of solitary fibrous tumor and 1 case of osteofibroma.There were 23 cases diagnosed as NETs by visual interpretation,of which 22 cases were NETs;9 cases were diagnosed as non-NETs,of which 4 cases were false negative.The sensitivity,specificity and accuracy of visual method to diagnose NETs were 84.62%,83.33%,84.38%,and the positive and negative predictive values were 95.65% and 55.56%,respectively.According to ROC analysis (T/Lratio cut-off value=1.48),21 cases were diagnosed as NETs and they were all consistent with pathological results;11 cases were diagnosed as non-NETs and false negative results were found in 5 cases.The sensitivity,specificity and accuracy of T/Lratio-ROC method to diagnose NETs were 80.80%,100%,84.38%,and the positive and negative predictive values were 100% and 54.55%,respectively.Conclusion Both visual interptetation and T/Lratio-ROC method have good diagnostic efficacy for NETs based on ^68Ga-DOTATATE PET/CT imaging.They can be used for the localization and diagnosis of NETs.
作者 麻广宇 关志伟 张晓军 张锦明 徐白萱 MA Guangyu;GUAN Zhiwei;ZHANG Xiaojun;ZHANG Jinming;XU Baixuan(Department of Nuclear Medicine,the First Medical Center,Chinese PLA General Hospital,Beijing,100853,China)
出处 《解放军医学院学报》 CAS 2020年第2期128-132,共5页 Academic Journal of Chinese PLA Medical School
基金 科技部国际合作项目(2009DFA32960).
作者简介 麻广宇,男,硕士,主治医师。研究方向:PET肿瘤显像。Email:mgy301@163.com;通信作者:张锦明,男,博士,研究员,副主任。Email:zhangjm301@163.com
  • 相关文献

参考文献1

二级参考文献97

  • 1Kohler G;Milstein C.Continuous cultures of fused cells secreting antibody of predefined specificity,1975(256).
  • 2Modlin IM,Oberg K,Chung DC,Jensen RT,de Herder WW,Thakker RV,Caplin M,Delle Fave G,Kaltsas GA,Krenning EP,Moss SF,Nilsson O,Rindi G,Salazar R,Ruszniewski P,Sundin A.Gastroenteropancreatic neuroendocrine tumours. The Lancet Oncology . 2008
  • 3RT Jensen,JF Battey,ER Spindel,RV Benya.International Union of Pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states. Pharmacology Reviews . 2008
  • 4Solcia,E,Kloppel,G,Sobin,LH. World Health Organization International histological classification of tumors. Histological typing of endocrine tumors . 2000
  • 5Mirco Bartolomei,Lisa Bodei,Concetta Cicco,Chiara Maria Grana,Marta Cremonesi,Edoardo Botteri,Silvia Melania Baio,Demetrio Aricò,Maddalena Sansovini,Giovanni Paganelli.Peptide receptor radionuclide therapy with 90Y-DOTATOC in recurrent meningioma[J]. European Journal of Nuclear Medicine and Molecular Imaging . 2009 (9)
  • 6I. Buchmann,M. Henze,S. Engelbrecht,M. Eisenhut,A. Runz,M. Sch?fer,T. Schilling,S. Haufe,T. Herrmann,U. Haberkorn.Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours[J]. European Journal of Nuclear Medicine and Molecular Imaging . 2007 (10)
  • 7P. Antunes,M. Ginj,H. Zhang,B. Waser,R. P. Baum,J. C. Reubi,H. Maecke.Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals?[J]. European Journal of Nuclear Medicine and Molecular Imaging . 2007 (7)
  • 8Wouter A. P. Breeman,Alfons M. Verbruggen.The 68Ge/68Ga generator has high potential, but when can we use 68Ga-labelled tracers in clinical routine?[J]. European Journal of Nuclear Medicine and Molecular Imaging . 2007 (7)
  • 9Sophia Koukouraki,Ludwig G. Strauss,Vassilios Georgoulias,Michael Eisenhut,Uwe Haberkorn,Antonia Dimitrakopoulou-Strauss.Comparison of the pharmacokinetics of 68Ga-DOTATOC and [18F]FDG in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy[J]. European Journal of Nuclear Medicine and Molecular Imaging . 2006 (10)
  • 10Damian Wild,J?rg S. Schmitt,Mihaela Ginj,Helmut R. M?cke,Bert F. Bernard,Eric Krenning,Marion Jong,Sandra Wenger,Jean-Claude Reubi.DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals[J]. European Journal of Nuclear Medicine and Molecular Imaging . 2003 (10)

共引文献11

同被引文献41

引证文献5

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部